![]() |
|
|
Vol. 299, Issue 3, 858-865, December 2001
Laboratory of Hepatobiology and Toxicology, Department of
Pharmacology (Z.Z., X.L., S.Y., M.vF., N.E., K.I., M.K., R.G.T.), and
Department of Radiation Oncology (J.A.R.), University of North
Carolina, Chapel Hill, North Carolina
Acute cyclosporin A (CsA) treatment inhibits mitochondrial respiration,
yet effects of chronic treatment remain unclear. Accordingly, the
effects of chronic CsA on oxygen metabolism in perfused rat liver and
isolated mitochondria were investigated. Basal rates of oxygen uptake
of around 120 µmol/g/h in isolated perfused livers from
vehicle-treated controls were elevated about 1.6-fold by chronic CsA
treatment. In the presence of ammonium chloride, a substrate for urea
synthesis, oxygen uptake was about 150 µmol/g/h and was increased
about 1.7-fold by CsA, indicating that chronic CsA treatment causes a
robust hypermetabolic state in the liver. In isolated mitochondria,
state 3 rates of oxygen uptake were increased about 1.6-fold by chronic
CsA treatment. Since significant increases in oxygen consumption could
cause hypoxia, the hypoxia marker pimonidazole was given. Pimonidazole
binding in the liver was increased about 3-fold by chronic CsA.
Moreover, intracellular calcium in Kupffer cells isolated from
vehicle-treated rats was not altered by CsA addition; however, in cells
isolated from chronic CsA-treated rats, CsA increased intracellular
calcium about 15-fold and prostaglandin E2
(PGE2) production 3.5-fold. Importantly, dietary
glycine (5%) largely blocked chronic CsA-induced activation of Kupffer
cells, blunted production of PGE2, prevented the
hypermetabolic state, and minimized tissue hypoxia. Taken together, it
is concluded that chronic CsA treatment causes a hypermetabolic state
leading to hypoxia and injury to the liver. It is hypothesized that CsA activates Kupffer cells and increases production of PGE2,
which alters mitochondria leading to a hypermetabolic state. Glycine inhibits activation of Kupffer cells thus preventing liver injury.
This article has been cited by other articles:
![]() |
S. J. Provencher and M. Gascon-Barre Effect of Cyclosporine A on Hepatic Compensatory Growth: Role of Calcium Status J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 58 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. U. Niemann, M. Saeed, H. Akbari, W. Jacobsen, L. Z. Benet, U. Christians, and N. Serkova Close Association Between the Reduction in Myocardial Energy Metabolism and Infarct Size: Dose-Response Assessment of Cyclosporine J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1123 - 1128. [Abstract] [Full Text] [PDF] |
||||